Concepedia

Mark Fuller

MF

Statistics

Publications

6

Citations

247

H-Index

6

Active since

2013

Affiliations

Thrombosis and Atherosclerosis Research Institute(Current)

McMaster University

Bayer (Canada)

LMC Diabetes & Endocrinology (Canada)

Mark Fuller is an author at Thrombosis and Atherosclerosis Research Institute specializing in diabetes, metabolic syndrome, and systems biology.

ORCID

Top concepts

Publications per year

2013–2022

6

Publications

6

The Effects of Diet on Occlusive Coronary Artery Atherosclerosis and Myocardial Infarction in Scavenger Receptor Class B, Type 1/Low-Density Lipoprotein Receptor Double Knockout Mice

Mark Fuller, Omid Dadoo, Viktoria Serkis et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2014 · 70 citations · Full text

Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice

Elizabeth J. White, Gabriel Gyulay, Šárka Lhoták et al. · Journal of Biological Chemistry · 2018 · 57 citations · Full text

AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D)

Lisa Chu, Sanjit K. Bhogal, Peter Lin et al. · Canadian Journal of Diabetes · 2022 · 38 citations · Full text

Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study

Lisa Chu, Mark Fuller, Kathyrn Jervis et al. · Clinical Therapeutics · 2021 · 30 citations · Full text

SR-BI in Bone Marrow Derived Cells Protects Mice from Diet Induced Coronary Artery Atherosclerosis and Myocardial Infarction

Ying Pei, Xing Chen, Dina Aboutouk et al. · PLoS ONE · 2013 · 27 citations · Full text

Rows per page

1–5 of 6